Work

HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.

Year: 2022
Type: article
Abstract: . Therefore, the expression of HOXC10/ABCC3 could be a novel biomarker for predicting the carboplatin resistance and the prognosis of OC patients.
Source: PubMed
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W4309246365
FWCI: 0.224
Cites: 26
Cited by: 2
Related to: 10